OxyContin Given New Lease On Life By Federal Circuit
In a surprising turnaround, the U.S. Court of Appeals for the Federal Circuit has vacated its earlier ruling that Purdue Pharma's patents for the blockbuster painkiller OxyContin were unenforceable, throwing the...To view the full article, register now.
Already a subscriber? Click here to view full article